Primary mediastinal large B-cell lymphoma from the clinic to genomics: Insights for pathologists

被引:1
作者
Fakhruddin, Najla [1 ]
Abou Dalle, Iman [1 ]
Chakhachiro, Zaher [1 ]
机构
[1] Amer Univ Beirut, Beirut, Lebanon
关键词
PMBL; Mediastinum; B cell lymphoma; Genetics; Mutations; Therapy; GRAY ZONE LYMPHOMA; HODGKIN LYMPHOMA; EXPRESSION; MUTATIONS; RECURRENT; DIAGNOSIS; REVEALS; GENE; IMMUNOCHEMOTHERAPY; TRANSPLANTATION;
D O I
10.1016/j.humpath.2024.105705
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary mediastinal large B-cell lymphoma (PMBL) is a mature aggressive B-cell lymphoma that arises in the anterior mediastinum, likely originating from thymic B cells. Initially considered a subtype of diffuse large B-cell lymphoma, PMBL has since been established as a distinct clinicopathologic entity due to its unique clinical, morphologic, immunophenotypic and genetic characteristics. PMBL primarily affects young adults, especially women, and manifests as a bulky mediastinal mass that can invade adjacent structures, often causing respiratory symptoms. The genomic landscape of PMBL includes alterations in the JAK-STAT, NF-kappa B signaling pathways, and immune evasion mechanisms. This review explores the clinical presentation, pathogenesis and genetic landscape of PMBL, highlighting its morphologic and immunophenotypic characteristics and differences from related mediastinal lymphomas such as classic Hodgkin lymphoma and mediastinal grey zone lymphoma. We also discuss the implications of these findings on diagnosis, management and personalized treatment approaches.
引用
收藏
页数:7
相关论文
共 72 条
  • [31] Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach
    Hayden, Anna R.
    Tonseth, Petter
    Lee, Derrick G.
    Villa, Diego
    Gerrie, Alina S.
    Scott, David W.
    Freeman, Ciara L.
    Slack, Graham W.
    Farinha, Pedro
    Skinnider, Brian
    Yenson, Paul R.
    Benard, Francois
    Lo, Andrea
    Pickles, Tom
    Wilson, Donald
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    [J]. BLOOD, 2020, 136 (24) : 2803 - 2811
  • [32] Jardin F PA, 2016, Am J Hematol, V19, P7
  • [33] Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
    Kim, Hyun-Jung
    Kim, Hee Kyung
    Park, Gyeongsin
    Min, Soo Kee
    Cha, Hee Jeong
    Lee, Hyekyung
    Choi, Suk Jin
    Na, Hee Young
    Choe, Ji-Young
    Kim, Ji Eun
    [J]. DIAGNOSTIC PATHOLOGY, 2019, 14 (01)
  • [34] Knorr F ZM, 2021, Haematologica, V106, P4
  • [35] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
  • [36] Racial patterns of patients with primary mediastinal large B-cell lymphoma SEER analysis
    Liu, Pan-Pan
    Wang, Ke-Feng
    Xia, Yi
    Bi, Xi-Wen
    Sun, Peng
    Wang, Yu
    Li, Zhi-Ming
    Jiang, Wen-Qi
    [J]. MEDICINE, 2016, 95 (27)
  • [37] Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
    Locke, Frederick L.
    Ghobadi, Armin
    Jacobson, Caron A.
    Miklos, David B.
    Lekakis, Lazaros J.
    Oluwole, Olalekan O.
    Lin, Yi
    Braunschweig, Ira
    Hill, Brian T.
    Timmerman, John M.
    Deol, Abhinav
    Reagan, Patrick M.
    Stiff, Patrick
    Flinn, Ian W.
    Farooq, Umar
    Goy, Andre
    McSweeney, Peter A.
    Munoz, Javier
    Siddiqi, Tanya
    Chavez, Julio C.
    Herrera, Alex F.
    Bartlett, Nancy L.
    Wiezorek, Jeffrey S.
    Navale, Lynn
    Xue, Allen
    Jiang, Yizhou
    Bot, Adrian
    Rossi, John M.
    Kim, Jenny J.
    Go, William Y.
    Neelapu, Sattva S.
    [J]. LANCET ONCOLOGY, 2019, 20 (01) : 31 - 42
  • [38] Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
    Mansouri, Larry
    Noerenberg, Daniel
    Young, Emma
    Mylonas, Elena
    Abdulla, Maysaa
    Frick, Mareike
    Asmar, Fazila
    Ljungstroem, Viktor
    Schneider, Markus
    Yoshida, Kenichi
    Skaftason, Aron
    Pandzic, Tatjana
    Gonzalez, Blanca
    Tasidou, Anna
    Waldhueter, Nils
    Rivas-Delgado, Alfredo
    Angelopoulou, Maria
    Ziepert, Marita
    Arends, Christopher Maximilian
    Couronne, Lucile
    Lenze, Dido
    Baldus, Claudia D.
    Bastard, Christian
    Okosun, Jessica
    Fitzgibbon, Jude
    Doerken, Bernd
    Drexler, Hans G.
    Roos-Weil, Damien
    Schmitt, Clemens A.
    Munch-Petersen, Helga D.
    Zenz, Thorsten
    Hansmann, Martin-Leo
    Strefford, Jonathan C.
    Enblad, Gunilla
    Bernard, Olivier A.
    Ralfkiaer, Elisabeth
    Erlanson, Martin
    Korkolopoulou, Penelope
    Hultdin, Magnus
    Papadaki, Theodora
    Gronbaek, Kirsten
    Lopez-Guillermo, Armando
    Ogawa, Seishi
    Kuppers, Ralf
    Stamatopoulos, Kostas
    Stavroyianni, Niki
    Kanellis, George
    Rosenwald, Andreas
    Campo, Elias
    Amini, Rose-Marie
    [J]. BLOOD, 2016, 128 (23) : 2666 - 2670
  • [39] Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas
    Meier, Cecile
    Hoeller, Sylvia
    Bourgau, Caroline
    Hirschmann, Petra
    Schwaller, Juerg
    Went, Philip
    Pileri, Stefano A.
    Reiter, Andreas
    Dirnhofer, Stephan
    Tzankov, Alexandar
    [J]. MODERN PATHOLOGY, 2009, 22 (03) : 476 - 487
  • [40] Mottok A HS, 2015, Blood, V134, P11